Glycoregimmune is a San Diego-based biotechnology company that is dedicated to advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic, and autoimmune diseases. Their approach focuses on targeting key steps in the inflammatory cascade to interrupt disease progression, with the advancement of their programs subject to additional funding and partnering.
With a strong emphasis on scientific research and development, Glycoregimmune aims to provide effective solutions for patients suffering from these debilitating conditions. By harnessing the potential of NKT cells, they strive to develop novel therapies that can make a significant impact on the lives of individuals affected by inflammatory, fibrotic, and autoimmune diseases.
Generated from the website